Recommanded Tools
AbSeek™ encompasses antibody sequence analysis, structure and function prediction, lead optimization, de novo generation, and visualization, among others, covering all stages of antibody discovery and engineering from screening to optimization for efficient innovation.
Free Tools Limited Time
Sequence Analysis
Function Prediction
Lead Optimization
Structure Prediction
New
Molecule Generation

Features & Advantages
Integration
Combines multiple algorithms to provide a one-stop service that meets all needs in antibody discovery and engineering.
Expertise
Tailors UI and data visualization methods based on the characteristics of antibody data for better suitability.
Advancement
Continuously updates cutting-edge AI algorithms to ensure the platform's timeliness and advancement.
Data Security
Committed to providing users with a secure and reliable data environment, alleviating concerns about data leakage.
News
Cyagen Talk|AI-Powered Antibody Discovery: From HUGO-Ab Mice to Predictive Models
AbSeek™: Intelligent Antibody Computational Platform
2025-03-19
More >>【Frontier Express】Molecular Cancer | USP7 as a Novel Immunotherapeutic Target for Microsatellite Stable Colorectal Cancer
2026-03-13
【Frontier Express】Molecular Cancer | DCLK1 Drives Bladder Cancer Malignant Progression and Chemoresistance by Deubiquitinating HDAC6
2026-03-13
【Frontier Express】Nature Reviews Microbiology | Biological Characteristics, Pathogenicity, Immune Evasion, and Control Strategies of SARS-CoV-2 Variants
2026-03-12
【Frontier Express】Nature Reviews Methods Primers | Extracellular Vesicle Analysis: A Comprehensive Guide from Sample Preparation to Functional Studies
2026-03-12
【Frontier Express】Nature Reviews Materials | Applications and Challenges of Biomaterials in Living Drug Delivery
2026-03-11
【Frontier Express】Nature Reviews Cancer | Compressive Stresses in Cancer: Characterization and Implications for Tumour Progression and Treatment
2026-03-11
【Frontier Express】Nature Medicine | Soluble MAdCAM-1 as a Prognostic Biomarker in Metastatic Renal Cell Carcinoma
2026-03-10






